Abstract P3-11-17: A novel biodynamic imaging assay predicts success or failure of neoadjuvant chemotherapy in breast cancer patients

Background: Use of neoadjuvant chemotherapy (NAC) in breast cancer patients has increased significantly over the past decade. The clinical benefits of NAC, including potential to downstage disease, facilitation of breast conserving surgery and use of pathologic response as a prognostic marker, are well established. However, with multiple regimens approved and recommended for NAC, choosing the optimal therapy for individual patients remains a challenge. Biodynamic imaging (BI), a novel technology that captures cellular motility in living tissue via Doppler spectroscopy, could be used ex-vivo to prospectively evaluate the efficacy of systemic therapies in patient tumor samples prior to treatment. This study aimed to determine whether BI could accurately predict likelihood of response to NAC in breast cancer patients.

Methods: Fresh core biopsies were obtained from 84 patients prospectively enrolled in an IRB-approved clinical trial at 5 institutions between 1/5/17 and 8/3/2018. Patient tumor tissue was collected at time of routine diagnostic biopsy and sent to a central laboratory where it was divided into intact tumor fragments measuring approximately 1mm in diameter. Fragments were placed into 96 well plates and imaged using the BI assay (Onco4D™), while being challenged by various cytotoxic agents for up to 20 hours. Cellular characteristics and motility signatures were evaluated and compared to pathologic NAC response established upon surgical resection (mastectomy or lumpectomy).

Results: At the time of this analysis, centrally-confirmed pathologic response data were available for 17 patients treated with doxorubicin/cyclophosphamide + taxane (AC). Pathologic outcomes are pending for an additional 8 AC patients. The remainder of the 84 patients initially enrolled in the study either did not receive NAC (n=10), have not yet selected a course of therapy (n=12), or received NAC regimens other than AC (n=37). Of the 17 currently evaluable AC-treated patients, 4 had triple negative (TN) disease, 12 were hormone receptor positive, and 1 hormone receptor negative patient showed equivocal HER2 results. Two of the TN patients were known to harbor pathogenic BRCA1 mutations and received carboplatin in addition to AC. Seven of 17 patients (40%) displayed resistance to AC (2 with progressive and 5 with stable disease) while 10 experienced objective response (8 partial and 2 complete response). A multilinear regression model using 10 BI markers accurately classified 16 of 17 patients (94%) while producing 1 false prediction of partial response for a patient with stable disease clinically (R-squared=0.9994, p<.0001). The positive predictive and negative predictive values of BI to AC response were 100% and 91%, respectively.

Table 1.Performance Characteristics  Clinical   OutcomeResponseNon-ResponseTotalClassifierResponse10111 Non-Response066 Total10717

Conclusion: BI was able to accurately predict patient response to neoadjuvant AC, demonstrating the potential for the platform to support personalized patient therapy. This clinical trial is ongoing and will report out results for TC (docetaxel/cyclophosphamide), TCHP (docetaxel/carboplatin/trastuzumab + pertuzumab), and additional AC patients as outcome data are accrued.

Citation Format: Whitacre E, Manahan E, Burak W, Morgan T, An R, Loesch D. A novel biodynamic imaging assay predicts success or failure of neoadjuvant chemotherapy in breast cancer patients [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-11-17.

[Diagnosis of diabetic autonomic neuropathy in young patients with diabetes mellitus type 1]

Autonomic neuropathy, particularly cardiovascular autonomic neuropathy (CAN) is one of the complications of the diabetes mellitus both types. It leads to life comfort's declination but may also be the direct cause of death in diabetes mellitus patients. It seems that degree of metabolic control and duration of the disease is connected with prevalence and severity of CAN. The aim of our study was to assess cardiac autonomic function in young subjects suffered from insulin-dependent diabetes mellitus (IDDM) with relatively short duration time of the disease. We subdivided 25 (m-12, f-13) IDDM patients aged from 18 to 30 years: mean--26 +/- 38 years, with duration time of the disease up to 10 years, normotensive and without nephropathy and retinopathy. We created 25 healthy volunteers control group with similar age and sex. In all selected subjects full Ewing's battery tests were performed as well as the spectral analysis of power heart rate variability (HRV) was assessed with Finapress device (Ohmeda 2300) and automatically computed with special software. HRV in total spectrum power TP from 0.001-0.5 Hz, high frequency (HF) band from 0.15-0.3 Hz, low frequency (LF) band from 0.03-0.15 Hz and LF/HF ratio were examined both in supine and tilt. All assessed spectral values were significantly lower in IDDM patients then these in controls whereas LF/HF were respectively higher. Valsalva tests and deep breathing HR response tests were significantly differed among groups but within normal limits. We concluded that when spectral analyse was performed, in young IDDM patients with short duration time of the disease, impairment of cardiac autonomic function was observed.

The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus

The dinucleotide repeat polymorphism (5'-ALR2) in the promoter region of the aldose reductase gene on chromosome 7q35 has been implicated in the development of diabetic nephropathy in Type I (insulin-dependent) diabetes mellitus, and markers flanking the aldose reductase locus have given evidence suggestive of a linkage between diabetic nephropathy and Type II (non-insulin-dependent) diabetes mellitus in Pima Indians. To examine whether the 5'-ALR2 polymorphism in the aldose reductase gene is involved in the development of diabetic nephropathy in Caucasians with Type II diabetes, we carried out a large association study. Patients with Type II diabetes from one outpatient clinic were screened for diabetic nephropathy and divided into three groups according to the degree of this disease: 179 patients with normoalbuminuria, 225 patients with microalbuminuria and 70 patients with proteinuria. Patients with normoalbuminuria were included in the study only if they had had Type II diabetes for 10 or more years. DNA from all patients was genotyped for the 5'-ALR2 polymorphism using a previously established polymerase chain reaction protocol. The frequency of the putative risk allele Z-2 was 34.6%, 34.2% and 33.6% in the normoalbuminuria, microalbuminuria and proteinuria groups, respectively. Similarly no difference among groups was found for the frequency of the putative protective allele Z + 2. In conclusion, the results of our association study in Caucasian patients with Type II diabetes do not support the hypothesis that the 5'-ALR2 polymorphism in the aldose reductase gene contributes to susceptibility to diabetic nephropathy.

[Changes in levels of atrial natriuretic peptide (ANP) in patients with chronic renal failure during physical exertion]

Many endocrine abnormalities were reported in patients with chronic renal failure (CRF), including elevated ANP, but little is known on ANP vaso-regulatory effects during exercise. This study is aimed to find whether plasma ANP rises during exercise in patients with CRF, as it does in normal subjects, and whether there is a difference between this response in both those groups. 36 subjects were studied, divided into three groups: I--CRF patients treated conservatively (nondialyzed), II--CRF patients, dialyzed, III--healthy subjects. Plasma ANP was measured at rest and then immediately after submaximal treadmill work load according to modified Bruce protocol with continuous ecg and blood pressure monitoring. In the CRF nondialyzed patients the metabolic equivalent (MET) was significantly lower than in the other groups. The myocardial oxygen consumption, estimated as double product quotient, was the lowest in the nondialyzed CRF patients. A significant increase of the plasma ANP was seen in all subjects studied, significantly higher in the CRF patients than in the control healthy subjects. No correlations were found between the plasma ANP level and other measured parameters.

[Effect of physical exertion on levels of vasopressin (AVP) and plasma renin activity in patients with chronic kidney failure]

In uraemic subjects many endocrine abnormalities were observed. Plasma vasopressin (AVP) levels and plasma renin activity (PRA) were significantly higher than in normals, but little is known about their vasoregulatory effects during exercise. The aim of our study was to find the answer on the following question: 1.were any significant changes in AVP and PRA levels during exercise in uremic patients and in normals occurred, 2.were any hormonal profile differences between nonhaemodialysed and haemodialysed patients existed, 3.does the correlation between blood pressure changes and AVP and PRA exist. Plasma AVP and PRA levels were measured in 12 uraemic non-haemodialysed subjects, in 12 uraemic haemodialysed subjects and in 12 healthy subjects. In all groups AVP and PRA were examined two times--first in normal conditions (rest) and second time after submaximal work load during ECG exercise test with continuous blood pressure monitoring. In nonhaemodialysed subjects METs value were significantly lower than in other groups. Mean increase of mean blood pressure was comparable between observed groups. We didn't find any significant correlation between changes in plasma AVP and PRA level and other measured parameters.

CONCLUSIONS

1. Exercise test induced qualitatively the same but quantitatively different changes in plasma AVP and PRA concentrations in uraemic and healthy subjects. 2.No significant differences in basal conditions as well as after exercise in plasma AVP and PRA between nonhaemodialysed and haemodialysed patients were observed. 3.No significant correlation between blood pressure and hormonal changes was found.

[Levels of beta-2-microglobulin (B2MG) in blood serum of patients during the early phase after kidney transplantation]

In uremic subjects serum B2MG levels was significantly higher than in normals. In kidney transplant patients (KTP) serum B2MG levels was 3-4 times higher than in normals. Elevated serum B2MG levels in KTP seems to depend not only on the kind of immunosuppressive therapy but also on other factors. In the present study we aimed to asses serum B2MG levels immediately after KT. B2MG were assessed in 25 uremic patients at the early phase after KT and in 12 controls (patients immediately after cholecystectomy). All uremic patients were divided on two groups: group I-patients with immediately graft function after transplantation (12 patients) and group II--patients with acute failure of the transplanted kidney (13 patients). In all examined subjects immediately before and 1, 2, 3, 4, 5, 10, 15, 20, 25, and 30 days after transplantation serum B2MG levels were assessed using RIA methods. In group I we observed gradually decline of B2MG concentrations parallel with creatinine after KT while in group II normalization of B2MG and creatinine levels were delayed (approximate 10 days). The significant positive correlation was found between plasma B2MG and creatinine levels in all examined patients. We concluded: 1. In all examined groups the tendency to normalization of B2MG levels after KT was observed. 2. Acute failure transplanted kidney delayed normalization of B2MG concentrations. 3. Normalization of B2MG levels was preferentially dependent on the graft function.

[Comparison of beta-2-agonist and beclomethasone effects on potassium levels, heart action and pulmonary ventilation parameters in patients with chronic asthmatic bronchitis]

The main goal of asthma treatment has usually been to maintain normal air potency with bronchodilators. A prompt improvement in physiologic measures of expiratory flow can be observed after administration beta-2-agonists or steroids. The present study aimed to assay the influence of fenoterol or beclomethasone therapy on the pulmonary ventilation (VC, FEV1, FEV1%), the heart action (heart rate, QT interval, 24 hours ECG) and the potassium balance in examined group. 20 patients with chronic asthmatic bronchitis were divided on two group (A and B). Group A consisted 10 subjects and patients were treated with fenoterol, the second group (Group B) consisted 10 subjects too, and patients were treated with beclomethasone. After five days treatment in all subjects an increase VC, FEV1 and FEV1% were observed. In group A (inhalation of fenoterol) we observed: 1--the significant increase of heart rate, QT interval, and frequency of cardiac arrhythmias and 2--significant decrease plasma potassium levels. In group B we didn't observed a significant changes in heart function and potassium levels. We concluded that nebulization of fenoterol, even in low doses, required control of the plasma potassium concentration and the evaluation of the heart action.

[Long-term oxygen therapy of chronic pulmonary heart disease]

Pulmonary artery pressure was measured in 70 patients with chronic bronchitis. Those with pulmonary hypertension underwent two hours oxygen therapy (flow 10-12 l/min). Those in whom a decrease of pulmonary artery pressure was observed were qualified for long term oxygen therapy (LTOT). In 32 patients which were qualified for LTOT, after a two week period of 18 hour per day oxygen therapy a decrease of systolic pulmonary arterial pressure from 336.1 mm Hg to 30.9 mm Hg and a decrease of mean pulmonary artery pressure from 25.9 to 23.2 mm Hg was observed.

[Selected parameters of the immune system in coal miners with pneumoconiosis]

The study was carried out in a group of 84 men divided in three groups: I--41 miners with simple pneumoconiosis, II--25 miners exposed to coal dust for the same period, and III--28 healthy persons of similar age (control group). All the persons were studied for absolute and proportional values of T and B lymphocytes, also subpopulation of TH helper lymphocytes and TS suppressor lymphocytes, a lymphocyte index (TH/TS) was determined. Besides, the concentration of serous immunoglobulins IgG, IgA and IgM was determined. The author showed a statistically significant decrease in the number of TS suppressor lymphocytes in the group of patients with pneumoconiosis and at the same time an increase in the lymphocyte index in comparison with the other groups. Besides, the author also found a significant decrease in the total amount of T lymphocytes in the same group and at the same time an increase in the concentrations of serous immunoglobulins IgG, IgA. The changes observed in the immunological system in patients with pneumoconiosis may lie at the bottom of the pathogenesis of fibrosis .